Drug profile · INN
peramivir
ALPIVAB
peramivir (ALPIVAB) is a neuraminidase inhibitor. Associated with Biocryst. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — peramivir
- US status
- approved
- Class
- Antiinfectives for systemic use (J05)
- Route
- INTRAVENOUS
- Patents
- 19
- Programs
- 7
- Data quality
- 0.89
Quick answer
peramivir (ALPIVAB) is a neuraminidase inhibitor. Associated with Biocryst. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Neuraminidase inhibitor
Primary target: Neuraminidase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11559515
Indole compounds and analogues thereof
granted -
US 11173159
Methods and compositions for inhibition of polymerase
granted -
US 10849883
Benzopyrazole compounds and analogues thereof
granted -
US 10420769
Methods and compositions for inhibition of polymerase
granted -
US 10391075
Antiviral treatments
granted -
US 10022375
Methods and compositions for inhibition of polymerase
granted -
US 9580428
Compositions and methods for inhibiting viral polymerase
granted -
US 9492452
Methods and compositions for inhibition of polymerase
granted -
US 8778997
Antiviral treatments
granted -
US 8163703
Hepatitis C therapies
granted -
US 8133870
Therapeutic furopyrimidines and thienopyrimidines
granted -
US 7514410
Hepatitis C therapies
granted -
US 7429571
Therapeutic furopyrimidines and thienopyrimidines
granted -
US 7045535
Compounds useful for inhibiting paramyxovirus neuraminidase
expired -
US 6835326
Fluorescent ink compositions comprising functionalized fluorescent nanocrystals
expired -
US 6680211
Fluorescent nanocrystal-embedded microspheres for fluorescence analysis
expired -
US 6576155
Fluorescent ink compositions comprising functionalized fluorescent nanocrystals
expired -
US 6458799
Deazaguanine analog, preparation thereof and use thereof
expired -
US 6268350
Polynucleotides for inhibiting metastasis and tumor cell growth
expired
Frequently asked questions
What is peramivir?
peramivir (ALPIVAB) is a neuraminidase inhibitor. Associated with Biocryst. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for peramivir?
ALPIVAB is a marketed brand name for peramivir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of peramivir?
peramivir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.